glp-1 news today september 2025 Alarming rise in weight loss drug overdoses September 2, 2025: U.S. compounding

The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025

Three transformative approachesLifeVantage MindBody GLP-1 supplementation, infrared sauna therapy, and cryotherapy offer benefits

with a GLP-1

Discover what GLP-1 agonists are, how they work, and why theyve become a popular weight loss solution.

Diabetes is prevalent worldwide and the number of patients is drastically rising, with a predication of 366 million in 2030 due to factors such as obesity, inactivity,

Given its multi-target efficacy and botanical safety profile, BBR represents a cost-effective adjuvant for obesity management, particularly in resource-limited settings